isoxazoles has been researched along with Diabetic Nephropathies in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheon, J; Jun, HS; Kim, D; Lee, GH | 1 |
| Hirata, T; Miyata, N; Roman, RJ; Smith, SV; Takahashi, T | 1 |
| Cha, DR; Cha, JJ; Han, JY; Han, SY; Kang, YS; Song, HK | 1 |
| Cui, ZH; Jiang, YJ; Jin, H; Jin, HF; Jin, JZ; Jin, YS; Li, C; Li, JJ; Piao, SG; Yang, CW; Zheng, HL | 1 |
| Chen, L; Jiang, H; Liu, H; Ren, Y; Shi, K; Wang, M; Wang, Z; Wei, M | 1 |
| Chen, Y; Feng, B; Gong, Y; Mu, J; Qin, Z; Shi, Z; Yuan, F; Zhang, J; Zhao, Y; Zhou, B | 1 |
| He, T; Ji, Y; Lv, W; Wang, J; Zhang, Q | 1 |
| Choi, JW; Jun, HS; Jung, JY; Li, HY; Oh, YS | 1 |
| Jiang, T; Levi, M; Wang, XX | 1 |
| Liu, JP; Ren, XJ; Wang, H; Wang, JY; Yu, WM | 1 |
| Kohan, DE; Pollock, DM | 1 |
| Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F | 1 |
2 review(s) available for isoxazoles and Diabetic Nephropathies
| Article | Year |
|---|---|
Nuclear hormone receptors in diabetic nephropathy.
Topics: Animals; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Heat-Shock Proteins; Hepatocyte Nuclear Factor 4; Humans; Hypolipidemic Agents; Isoxazoles; Liver X Receptors; Orphan Nuclear Receptors; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Receptors, Calcitriol; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Thiazolidinediones; Transcription Factors; Vitamin D | 2010 |
Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.
Topics: Animals; Clinical Trials as Topic; Diabetic Nephropathies; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Isoxazoles; Kidney Failure, Chronic; Pyridines; Pyrimidines; Renal Dialysis; Renal Insufficiency, Chronic; Thiophenes; Treatment Outcome | 2013 |
10 other study(ies) available for isoxazoles and Diabetic Nephropathies
| Article | Year |
|---|---|
Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
Topics: Actins; Animals; Cadherins; Diabetic Nephropathies; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Factor V; Fibronectins; Fibrosis; Glycerophospholipids; Isoxazoles; JNK Mitogen-Activated Protein Kinases; Kidney Tubules; Kruppel-Like Transcription Factors; Lysophospholipids; Mice; Propionates; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Transcription Factors; Vimentin | 2022 |
Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.
Topics: Animals; Diabetic Nephropathies; Fibrosis; Hypertension, Renal; Isoxazoles; Kidney; Lysophospholipids; Male; Propionates; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley | 2021 |
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
Topics: Adipose Tissue; Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Insulin Resistance; Isoxazoles; Kidney; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear | 2021 |
Synergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Benzazepines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Synergism; Isoxazoles; Leflunomide; Male; Rats; Rats, Wistar; Treatment Outcome | 2014 |
Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.
Topics: Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Intramolecular Oxidoreductases; Isoxazoles; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Inbred C57BL | 2014 |
Activation of farnesoid X receptor downregulates visfatin and attenuates diabetic nephropathy.
Topics: Animals; Cell Line; Cell Proliferation; Cytokines; Diabetic Nephropathies; Disease Models, Animal; Gene Expression Regulation; Humans; Isoxazoles; Male; Mesangial Cells; Mice; Nicotinamide Phosphoribosyltransferase; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Transcription, Genetic | 2016 |
Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy.
Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Urea Nitrogen; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Male; Organ Size; Osteopontin; Rats, Wistar; Transforming Growth Factor beta1 | 2016 |
Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Topics: Animals; Cell Line; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3 beta; Isoxazoles; Kidney Cortex; Lysophospholipids; Male; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Phosphorylation; Propionates; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction; Smad2 Protein; Smad3 Protein; Sterol Regulatory Element Binding Protein 1; Time Factors; Transfection; Transforming Growth Factor beta | 2017 |
Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Chemokine CCL2; Creatinine; Cytoprotection; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Inflammation Mediators; Isoxazoles; Kidney; Leflunomide; Male; Nephrectomy; NF-kappa B; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2012 |
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2000 |